| Year |
Citation |
Score |
| 2020 |
Wang M, Irvin TC, Herdman CA, Hanna RD, Hassan SA, Lee YS, Kaska S, Crowley RS, Prisinzano TE, Withey SL, Paronis CA, Bergman J, Inan S, Geller EB, Adler MW, et al. The Intriguing Effects of Substituents in the -Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of "Tail Wags Dog" Experiments. Molecules (Basel, Switzerland). 25. PMID 32517185 DOI: 10.3390/Molecules25112640 |
0.316 |
|
| 2018 |
Paronis CA, Chopda GR, Vemuri K, Zakarian AS, Makriyannis A, Bergman J. Long-lasting in vivo effects of the cannabinoid CB1 antagonist AM6538. The Journal of Pharmacology and Experimental Therapeutics. PMID 29311110 DOI: 10.1124/Jpet.117.245647 |
0.347 |
|
| 2015 |
Nikas SP, Sharma R, Paronis CA, Kulkarni S, Thakur GA, Hurst D, Wood JT, Gifford RS, Rajarshi G, Liu Y, Raghav JG, Guo JJ, Järbe TU, Reggio PH, Bergman J, et al. Probing the carboxyester side chain in controlled deactivation (-)-δ(8)-tetrahydrocannabinols. Journal of Medicinal Chemistry. 58: 665-81. PMID 25470070 DOI: 10.1021/Jm501165D |
0.314 |
|
| 2013 |
Sharma R, Nikas SP, Paronis CA, Wood JT, Halikhedkar A, Guo JJ, Thakur GA, Kulkarni S, Benchama O, Raghav JG, Gifford RS, Järbe TU, Bergman J, Makriyannis A. Controlled-deactivation cannabinergic ligands. Journal of Medicinal Chemistry. 56: 10142-57. PMID 24286207 DOI: 10.1021/Jm4016075 |
0.31 |
|
| 2013 |
Chopda GR, Vemuri VK, Sharma R, Thakur GA, Makriyannis A, Paronis CA. Diuretic effects of cannabinoid agonists in mice. European Journal of Pharmacology. 721: 64-9. PMID 24099963 DOI: 10.1016/J.Ejphar.2013.09.053 |
0.329 |
|
| 2013 |
Thakur GA, Bajaj S, Paronis C, Peng Y, Bowman AL, Barak LS, Caron MG, Parrish D, Deschamps JR, Makriyannis A. Novel adamantyl cannabinoids as CB1 receptor probes. Journal of Medicinal Chemistry. 56: 3904-21. PMID 23621789 DOI: 10.1021/Jm4000775 |
0.319 |
|
| 2013 |
Paronis CA, Thakur GA, Bajaj S, Nikas SP, Vemuri VK, Makriyannis A, Bergman J. Diuretic effects of cannabinoids. The Journal of Pharmacology and Experimental Therapeutics. 344: 8-14. PMID 23019138 DOI: 10.1124/Jpet.112.199331 |
0.372 |
|
| 2012 |
Paronis CA, Nikas SP, Shukla VG, Makriyannis A. Δ(9)-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice. Behavioural Pharmacology. 23: 802-5. PMID 23075707 DOI: 10.1097/Fbp.0B013E32835A7C4D |
0.3 |
|
| 2008 |
Bergman J, Delatte MS, Paronis CA, Vemuri K, Thakur GA, Makriyannis A. Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties. Physiology & Behavior. 93: 666-70. PMID 18076956 DOI: 10.1016/J.Physbeh.2007.11.007 |
0.316 |
|
| 2007 |
Desai RI, Neumeyer JL, Paronis CA, Nguyen P, Bergman J. Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeys. European Journal of Pharmacology. 558: 98-106. PMID 17207791 DOI: 10.1016/J.Ejphar.2006.11.042 |
0.332 |
|
| 2000 |
Kishioka S, Paronis CA, Lewis JW, Woods JH. Buprenorphine and methoclocinnamox: agonist and antagonist effects on respiratory function in rhesus monkeys. European Journal of Pharmacology. 391: 289-97. PMID 10729371 DOI: 10.1016/S0014-2999(00)00039-X |
0.322 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2001 |
Ryan C, Hudzik TJ, Yanek M, Porrey T, Evenden J, Paronis C, Mastrangelo M, Ross SB, Stenfors C. AR-A000002, a high affinity 5-HT1B receptor antagonist: Evaluation of its anxiolytic potential European Neuropsychopharmacology. 11. DOI: 10.1016/S0924-977X(01)80420-X |
0.296 |
|
| 2010 |
Nikas SP, Alapafuja SO, Papanastasiou I, Paronis CA, Shukla VG, Papahatjis DP, Bowman AL, Halikhedkar A, Han X, Makriyannis A. Novel 1',1'-chain substituted hexahydrocannabinols: 9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a highly potent cannabinoid receptor 1 (CB1) agonist. Journal of Medicinal Chemistry. 53: 6996-7010. PMID 20925434 DOI: 10.1021/Jm100641G |
0.29 |
|
| 1994 |
Paronis CA, Holtzman SG. Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists. Psychopharmacology. 114: 601-10. PMID 7855222 DOI: 10.1007/BF02244991 |
0.29 |
|
| 2007 |
Desai RI, Neumeyer JL, Paronis CA, Nguyen P, Bergman J. Erratum to: Behavioral effects of the R-(+)- and S-(−)-enantiomers of the dopamine D1-like partial receptor agonist SKF 83959 in monkeys [European Journal of Pharmacology 558 (2007) 98106] European Journal of Pharmacology. 575: 187. DOI: 10.1016/J.Ejphar.2007.08.013 |
0.288 |
|
| 2008 |
Delatte MS, Paronis CA. Evaluation of cannabinoid agonists using punished responding and midazolam discrimination procedures in squirrel monkeys. Psychopharmacology. 198: 521-8. PMID 17882403 DOI: 10.1007/s00213-007-0918-5 |
0.288 |
|
| 2003 |
Yasar S, Bergman J, Munzar P, Redhi G, Tober C, Knebel N, Zschiesche M, Paronis C. Evaluation of the novel antiepileptic drug, AWD 131-138, for benzodiazepine-like discriminative stimulus and reinforcing effects in squirrel monkeys. European Journal of Pharmacology. 465: 257-65. PMID 12681437 DOI: 10.1016/S0014-2999(03)01533-4 |
0.287 |
|
| 1993 |
Paronis CA, Waddell AB, Holtzman SG. Naltrexone in vivo protects mu receptors from inactivation by beta-funaltrexamine, but not kappa receptors from inactivation by nor-binaltorphimine. Pharmacology, Biochemistry, and Behavior. 46: 813-7. PMID 8309960 DOI: 10.1016/0091-3057(93)90206-9 |
0.287 |
|
| 2007 |
Paronis CA, Thakur GA, Vemuri K, Makriyannis A, Bergman J. Effects of a Selective Cannabinoid Agonist and Antagonist on Body Temperature in Rats The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A409 |
0.285 |
|
| 2023 |
Withey SL, Bergman J, Paronis CA. . The Journal of Pharmacology and Experimental Therapeutics. PMID 37699710 DOI: 10.1124/jpet.122.001570 |
0.285 |
|
| 1998 |
Paronis CA, Bergman J. AGONIST AND ANTAGONIST EFFECTS OF GABAA MODULATORS Behavioural Pharmacology. 9: S70. DOI: 10.1097/00008877-199808000-00159 |
0.277 |
|
| 1992 |
Paronis CA, Holtzman SG. Apparent pA2 value of naltrexone is not changed in rats following continuous exposure to morphine or naloxone. Life Sciences. 50: 1407-16. PMID 1573974 DOI: 10.1016/0024-3205(92)90259-R |
0.276 |
|
| 1997 |
Paronis CA, Woods JH. Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats. European Journal of Pharmacology. 337: 27-34. PMID 9389377 DOI: 10.1016/S0014-2999(97)01296-X |
0.275 |
|
| 2021 |
Papanastasiou IP, Georgiadis MO, Iliopoulos-Tsoutsouvas C, Paronis CA, Brust CA, Tran NK, Ji L, Ma X, Wood JT, Zvonok N, Tong F, Bohn LM, Nikas SP, Makriyannis A. Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists. European Journal of Medicinal Chemistry. 230: 114027. PMID 35051750 DOI: 10.1016/j.ejmech.2021.114027 |
0.273 |
|
| 2003 |
Hudzik TJ, Yanek M, Porrey T, Evenden J, Paronis C, Mastrangelo M, Ryan C, Ross S, Stenfors C. Behavioral pharmacology of AR-A000002, a novel, selective 5-hydroxytryptamine(1B) antagonist. The Journal of Pharmacology and Experimental Therapeutics. 304: 1072-84. PMID 12604684 DOI: 10.1124/JPET.102.045468 |
0.273 |
|
| 2010 |
Desai RI, Paronis CA, Martin J, Desai R, Bergman J. Monoaminergic psychomotor stimulants: discriminative stimulus effects and dopamine efflux. The Journal of Pharmacology and Experimental Therapeutics. 333: 834-43. PMID 20190012 DOI: 10.1124/Jpet.110.165746 |
0.272 |
|
| 2011 |
Paronis CA, Bergman J. Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawal. The Journal of Pharmacology and Experimental Therapeutics. 336: 488-95. PMID 21051498 DOI: 10.1124/Jpet.110.173823 |
0.27 |
|
| 2004 |
Gasior M, Paronis CA, Bergman J. Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys. The Journal of Pharmacology and Experimental Therapeutics. 308: 249-59. PMID 14563783 DOI: 10.1124/Jpet.103.052795 |
0.267 |
|
| 2022 |
Chambers DR, Sulima A, Luo D, Prisinzano TE, Goldberg A, Xie B, Shi L, Paronis CA, Bergman J, Nassehi N, Selley DE, Imler GH, Jacobson AE, Rice KC. A Journey through Diastereomeric Space: The Design, Synthesis, In Vitro and In Vivo Pharmacological Activity, and Molecular Modeling of Novel Potent Diastereomeric MOR Agonists and Antagonists. Molecules (Basel, Switzerland). 27. PMID 36234992 DOI: 10.3390/molecules27196455 |
0.263 |
|
| 2016 |
Chopda GR, Parge VA, Thakur G, Gatley SJ, Makriyannis A, Paronis CA. Tolerance to the diuretic effects of cannabinoids and cross-tolerance to a kappa-opioid agonist in THC-treated mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 27231154 DOI: 10.1124/Jpet.116.232132 |
0.258 |
|
| 2021 |
de Moura FB, Sherwood A, Prisinzano TE, Paronis CA, Bergman J, Kohut SJ. Reinforcing effects of synthetic cathinones in rhesus monkeys: Dose-response and behavioral economic analyses. Pharmacology, Biochemistry, and Behavior. 173112. PMID 33444603 DOI: 10.1016/j.pbb.2021.173112 |
0.256 |
|
| 2001 |
Paronis CA, Cox ED, Cook JM, Bergman J. Different types of GABA(A) receptors may mediate the anticonflict and response rate-decreasing effects of zaleplon, zolpidem, and midazolam in squirrel monkeys. Psychopharmacology. 156: 461-8. PMID 11498724 DOI: 10.1007/S002130100754 |
0.253 |
|
| 2005 |
Gasior M, Bergman J, Kallman MJ, Paronis CA. Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 758-64. PMID 15526000 DOI: 10.1038/Sj.Npp.1300593 |
0.253 |
|
| 2016 |
Kulkarni S, Nikas SP, Sharma R, Jiang S, Paronis CA, Leonard MZ, Zhang B, Honrao C, Mallipeddi S, Raghav JG, Benchama O, Järbe TU, Bergman J, Makriyannis A. Novel C-Ring-Hydroxy-substituted Controlled Deactivation Cannabinergic Analogues. Journal of Medicinal Chemistry. PMID 27367336 DOI: 10.1021/Acs.Jmedchem.6B00717 |
0.252 |
|
| 2023 |
Lutz JA, Sulima A, Gutman ES, Bow EW, Luo D, Kaska S, Prisinzano TE, Paronis CA, Bergman J, Imler GH, Kerr AT, Jacobson AE, Rice KC. Discovery of a Potent Highly Biased MOR Partial Agonist among Diastereomeric C9-Hydroxyalkyl-5-phenylmorphans. Molecules (Basel, Switzerland). 28. PMID 37375350 DOI: 10.3390/molecules28124795 |
0.247 |
|
| 2019 |
Withey SL, Spealman RD, Bergman J, Paronis CA. Behavioral Effects of Opioid Full and Partial Agonists During Chronic Buprenorphine Treatment. The Journal of Pharmacology and Experimental Therapeutics. PMID 31413139 DOI: 10.1124/Jpet.119.259010 |
0.244 |
|
| 2006 |
Paronis CA. Modulating GABA modulators. British Journal of Pharmacology. 147: 237-8. PMID 16331288 DOI: 10.1038/sj.bjp.0706552 |
0.239 |
|
| 2022 |
Paronis C, Iliopoulos-Tsoutsouvas C, Papanastasiou I, Makriyannis A, Bergman J, Nikas SP. Evidence for spontaneous cannabinoid withdrawal in mice. Behavioural Pharmacology. 33: 184-194. PMID 35288509 DOI: 10.1097/FBP.0000000000000665 |
0.23 |
|
| 2018 |
Withey SL, Paronis CA, Bergman J. Concurrent Assessment of the Antinociceptive and Behaviorally Disruptive Effects of Opioids in Squirrel Monkeys. The Journal of Pain : Official Journal of the American Pain Society. PMID 29477761 DOI: 10.1016/J.Jpain.2018.02.003 |
0.229 |
|
| 2007 |
Desai RI, Neumeyer JL, Bergman J, Paronis CA. Pharmacological characterization of the effects of dopamine D(1) agonists on eye blinking in rats. Behavioural Pharmacology. 18: 745-54. PMID 17989512 DOI: 10.1097/Fbp.0B013E3282F14Ee6 |
0.227 |
|
| 2005 |
Delatte M, Paronis C, Ahring P, Mirza N. A49 THE EFFECTS OF NOVEL BENZODIAZEPINE-SITE LIGANDS IN MIDAZOLAM-DISCRIMINATING SQUIRREL MONKEYS Behavioural Pharmacology. 16: S39. DOI: 10.1097/00008877-200509001-00122 |
0.224 |
|
| 2018 |
Chopda GR, Nikas SP, Sharma R, Kulkarni S, Makriyannis A, Paronis CA. Cannabinoid-induced lower lip retraction in rats. Psychopharmacology. PMID 30460515 DOI: 10.1007/S00213-018-5125-Z |
0.222 |
|
| 2005 |
Paronis C, Delatte M, Ahring P, Mirza N. A48 THE EFFECTS OF NOVEL BENZODIAZEPINE-SITE LIGANDS ON PUNISHED RESPONDING IN SQUIRREL MONKEYS Behavioural Pharmacology. 16: S38-S39. DOI: 10.1097/00008877-200509001-00121 |
0.218 |
|
| 1998 |
Paronis CA. ANTAGONISM OF THE DISCRIMINATIVE STIMULUS EFFECTS OF MIDAZOLAM BY FLUMAZENIL AND BRETAZENIL IN SQUIRREL MONKEYS Behavioural Pharmacology. 9: S117. DOI: 10.1097/00008877-199808000-00272 |
0.21 |
|
| 2020 |
Erwin L, Nikas S, Makriyannis A, Paronis C. Discriminative Stimulus Effects of (R)(−)‐DOI and AM8936, a Synthetic Cannabinoid The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.06003 |
0.208 |
|
| 2002 |
Paronis CA, Gasior M, Bergman J. Effects of cocaine under concurrent fixed ratio schedules of food and IV drug availability: a novel choice procedure in monkeys. Psychopharmacology. 163: 283-91. PMID 12373429 DOI: 10.1007/S00213-002-1180-5 |
0.196 |
|
| 2000 |
Kishioka S, Paronis CA, Woods JH. Acute dependence on, but not tolerance to, heroin and morphine as measured by respiratory effects in rhesus monkeys. European Journal of Pharmacology. 398: 121-30. PMID 10856456 DOI: 10.1016/S0014-2999(00)00279-X |
0.196 |
|
| 2021 |
Wakeford AGP, Sherwood AM, Prisinzano TE, Bergman J, Kohut SJ, Paronis CA. Discriminative-stimulus effects of synthetic cathinones in squirrel monkeys. The International Journal of Neuropsychopharmacology. PMID 33909067 DOI: 10.1093/ijnp/pyab017 |
0.176 |
|
| 2023 |
Kaufman MJ, Meloni EG, Qrareya AN, Paronis CA, Bogin V. Effects of inhaled low-concentration xenon gas on naltrexone-precipitated withdrawal symptoms in morphine-dependent mice. Drug and Alcohol Dependence. 255: 110967. PMID 38150894 DOI: 10.1016/j.drugalcdep.2023.110967 |
0.167 |
|
| 2006 |
Bergman J, Paronis CA. Measuring the reinforcing strength of abused drugs. Molecular Interventions. 6: 273-83. PMID 17035668 DOI: 10.1124/Mi.6.5.9 |
0.1 |
|
| 1996 |
KISHIOKA S, PARONIS CA, WOODS JH. THE DDD (DRUG DISCRIMINATION DATABASE) ON THE WWW (WORLD WIDE WEB) Behavioural Pharmacology. 7: 56. DOI: 10.1097/00008877-199605001-00126 |
0.093 |
|
| 2013 |
Paronis CA. Ethanol self-administration in rats responding under concurrent schedules for milk or ethanol plus milk. Behavioural Pharmacology. 24: 486-95. PMID 23903243 DOI: 10.1097/FBP.0b013e328364c006 |
0.084 |
|
| 2022 |
Missig G, Mehta N, Robbins JO, Good CH, Iliopoulos-Tsoutsouvas C, Makriyannis A, Nikas SP, Bergman J, Carlezon WA, Paronis CA. Altered sleep during spontaneous cannabinoid withdrawal in male mice. Behavioural Pharmacology. 33: 195-205. PMID 35288510 DOI: 10.1097/FBP.0000000000000674 |
0.069 |
|
| 2003 |
Kassel JD, Stroud LR, Paronis CA. Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking. Psychological Bulletin. 129: 270-304. PMID 12696841 DOI: 10.1037/0033-2909.129.2.270 |
0.017 |
|
| Hide low-probability matches. |